Our study identified DOCK3 as a crucial player in PCa, particularly highlighting its ​novel dual role in promoting metastasis while concurrently modulating immune infiltration—a phenomenon not extensively reported in prostate cancer prior to this work. This evidence concerns the gene DOCK3 and prostate cancer.